Page last updated: 2024-12-06

8-azaadenine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

8-azaadenine: xanthine oxidase inhibitor [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

8-azaadenine : A triazolopyrimidine that is [1,2,3]triazolo[4,5-d]pyrimidine bearing an amino substituent at position 7. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID70746
CHEMBL ID3977487
CHEBI ID77751
SCHEMBL ID24639
SCHEMBL ID5134211
MeSH IDM0049301

Synonyms (75)

Synonym
BIDD:GT0280
AC-19696
BB 0262484
7-amino-v-triazolo[d]pyrimidine
1h-v-triazolo[4, 7-amino-
adenine, 8-aza-
6-amino-8-azapurine
1h-1,3-triazolo[4,5-d]pyrimidin-7-amine
7-amino-1-v-triazolo[d]pyrimidine
nsc-32797
nsc32797
3h-n-triazolo[4,5-d]pyrimidin-7-amine
inchi=1/c4h4n6/c5-3-2-4(7-1-6-3)9-10-8-2/h1h,(h3,5,6,7,8,9,10
1h-1,2,3-triazolo[4,5-d]pyrimidin-7-amine
3h-[1,2,3]triazolo[4,5-d]pyrimidin-7-amine
8-azaadenine
1123-54-2
3h-triazolo[4,5-d]pyrimidin-7-amine
OPREA1_309328
OPREA1_765299
8-azaadenine, >=99%
7-amino-1-v-triazolo(d)pyrimidine
7-amino-1h-v-triazolo(4,5-d)pyrimidine
1h-1,2,3-triazolo(4,5-d)pyrimidin-7-amine
7-amino-1h-triazolo(4,5-d)pyrimidine
8-azapurine, 6-amino-
3h-n-triazolo(4,5-d)pyrimidin-7-amine
einecs 214-375-5
1h-v-triazolo(4,5-d)pyrimidine, 7-amino-
nsc 32797
1h-v-triazolo(4,5-d)pyrimidin-7-amine
7-amino-v-triazolo(d)pyrimidine
STK501250
A0552
8-aza-6-aminopurine
2h-triazolo[4,5-d]pyrimidin-7-amine
AKOS003368188
AKOS004910265
unii-wpp3r9u93j
wpp3r9u93j ,
3h-1,2,3-triazolo(4,5-d)pyrimidin-7-amine
3h-[1,2,3]triazolo[4,5-d]pyrimidin-7-ylamine
A15128
c4h4n6
FT-0601385
2h-1,2,3-triazolo[4,5-d]pyrimidin-7-amine
337915-46-5
azaadenine, 8-
AM83921
7-amino-1h-triazolo[4,5-d]pyrimidine
SCHEMBL24639
SCHEMBL5134211
DTXSID0061537
8-azadenine
1h-[1,2,3]triazolo[4,5-d]pyrimidin-7-amine
CHEBI:77751
TS-00030
3h-[1,2,3]triazolo[4,5-d]pyrimidin-7-amine #
CHEMBL3977487
W-108648
2h-[1,2,3]triazolo[4,5-d]pyrimidin-7-amine
3h-1,2,3-triazolo[4,5-d]pyrimidin-7-amine
CS-W008550
8-azaadenine, 97%
benzenepropanol,4-methoxy-3-(3-methoxypropoxy)-b-(1-methylethyl)-,(br)-
mfcd00005697
2h-1,2,3-triazolo[4,5-d]pyrimidin-7-amine (9ci)
Q27147340
BCP27241
BBL037228
W18787
SB75636
SY019871
mfcd00778514
EN300-7129618
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
EC 1.17.3.2 (xanthine oxidase) inhibitorAn EC 1.17.3.* (oxidoreductase acting on CH or CH2 with oxygen as acceptor) inhibitor that interferes with the action of xanthine oxidase (EC 1.17.3.2).
Mycoplasma genitalium metaboliteAny bacterial metabolite produced during a metabolic reaction in Mycoplasma genitalium.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
triazolopyrimidines
aromatic amineAn amino compound in which the amino group is linked directly to an aromatic system.
nucleobase analogueA molecule that can substitute for a normal nucleobase in nucleic acids.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID1452128Inhibition of ATPgammaS-BODIPY binding to Thermotoga maritima His-tagged HK853 expressed in Escherichia coli BL21(DE3)pLysS Rosetta preincubated for 30 mins prior to ATPgammaS-BODIPY addition measured after 1 hr by coomassie staining-based SDS-PAGE analys2017Journal of medicinal chemistry, 10-12, Volume: 60, Issue:19
Rational Design of Selective Adenine-Based Scaffolds for Inactivation of Bacterial Histidine Kinases.
AID1324539Cytotoxicity against African green monkey Vero cells incubated for 24 hrs by neutral red uptake assay2016Journal of medicinal chemistry, 12-08, Volume: 59, Issue:23
In Silico Discovery and Validation of Amide Based Small Molecule Targeting the Enzymatic Site of Shiga Toxin.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (29)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (31.03)18.7374
1990's7 (24.14)18.2507
2000's7 (24.14)29.6817
2010's6 (20.69)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 18.52

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index18.52 (24.57)
Research Supply Index3.47 (2.92)
Research Growth Index4.35 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (18.52)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (3.23%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other30 (96.77%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]